Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Exchange Rate Effect (2021 - 2025)

Veracyte (VCYT) has disclosed Exchange Rate Effect for 5 consecutive years, with $12000.0 as the latest value for Q4 2025.

  • Quarterly Exchange Rate Effect rose 102.99% to $12000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $719000.0 through Dec 2025, up 269.58% year-over-year, with the annual reading at $719000.0 for FY2025, 269.58% up from the prior year.
  • Exchange Rate Effect hit $12000.0 in Q4 2025 for Veracyte, down from $60000.0 in the prior quarter.
  • In the past five years, Exchange Rate Effect ranged from a high of $732000.0 in Q4 2022 to a low of -$1.8 million in Q2 2021.
  • Historically, Exchange Rate Effect has averaged -$86736.8 across 5 years, with a median of $12000.0 in 2025.
  • Biggest five-year swings in Exchange Rate Effect: tumbled 771.43% in 2024 and later surged 1039.34% in 2025.
  • Year by year, Exchange Rate Effect stood at $164000.0 in 2021, then surged by 346.34% to $732000.0 in 2022, then tumbled by 59.43% to $297000.0 in 2023, then tumbled by 235.02% to -$401000.0 in 2024, then skyrocketed by 102.99% to $12000.0 in 2025.
  • Business Quant data shows Exchange Rate Effect for VCYT at $12000.0 in Q4 2025, $60000.0 in Q3 2025, and $573000.0 in Q2 2025.